DNA Methylation Profile of the SOCS-1 Gene Promoter in Smokers Patients With Chronic Periodontitis.
Effect of Smoking on the DNA Methylation Profile of the SOCS 1 Gene Promoter in Oral Mucosal Epithelial Cells of Individuals With Chronic Periodontitis (Smokers and Nonsmokers).
1 other identifier
observational
60
1 country
1
Brief Summary
Periodontitis is related to host genetics, constitution of the dental biofilm and environmental factors such as smoking. DNA methylation is a mechanism of genetic expression that can inhibit or silence gene expression. In this way several researchers have been dedicated to study the genetic influence on the susceptibility and / or increased risk to periodontal disease. Studies have reported association between several epigenetic biomarkers with periodontal inflammation. Considering the hypothesis that there is an association between smoking and methylation in genes related to periodontal disease, the objective of this study was to verify the DNA methylation pattern in oral epithelial cells of patients with chronic periodontitis (CP) in the promoter of a specific gene involved in the control of inflammation, as suppressor of cytokine signaling (SOCS) 1 in smokers and nonsmokers patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 6, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 18, 2017
CompletedFirst Submitted
Initial submission to the registry
November 30, 2017
CompletedFirst Posted
Study publicly available on registry
December 13, 2017
CompletedDecember 13, 2017
December 1, 2017
1.4 years
November 30, 2017
December 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Extraction of genomic DNA from oral epithelial cells
Epithelial cells were collected after mouthwash with 5ml dextrose autoclaved 3% and stored under refrigeration at -20ºC. After collection, the samples were taken to the Epigenetics and Reproduction Laboratory of the Department of Genetics of the Medical School of Ribeirão Preto-USP (FMRP-USP) where nucleic acid extraction and molecular analysis were performed. After thawing the saliva, 2ml of each sample collected were transferred separately to eppendorf tubes, for processing. The material was then diluted in 50 μl of cobalt Mili-Q water, incubated at 37 ° C in a water bath for 1 hour and stored in a freezer at -20 ° C. At the end, DNA quality, purity and integrity were measured using a spectrophotometer (NanoDrop 2000-Thermo Scientific), using OD 260/280 and 260/230. Considering ideal values for both reasons, between 1.8 and 2.2.
Baseline (at the beginning of the study)
Secondary Outcomes (3)
Probing pocket depth (PD)
Baseline (at the beginning of the study)
Plaque index (PI)
Baseline (at the beginning of the study)
Bleeding on probing (BOP)
Baseline (at the beginning of the study)
Study Arms (1)
Smokers/Non-smokers
It was an experimental study with parallel controls, comparing two groups, a group with patients who smoked for more than 10 years, consuming 10 more cigarettes per day and diagnosing chronic periodontitis (case) and another group (control) were non-smokers with chronic periodontitis, according to the standard of World Health Organization (WHO) definition of the smoking population
Interventions
rinsing with 3% sucrose, for a single time of collection, patients received periodontal treatment after collection and data analysis.
Eligibility Criteria
Patients who smoked for more than 10 years, consuming 10 more cigarettes per day and diagnosing chronic periodontitis (case) and another group (control) were non-smokers with chronic periodontitis, according to the standard of WHO definition of the smoking population,The ChP was diagnose in accordance with the recommended standards from the Center for Disease control and Prevention, the American Academy of Periodontology on the condition of patients in good general health, aged over 30 years, presenting with pocket periodontal disease with CAL ≥ 5 mm and radiographic bone loss and bleeding after probing.
You may qualify if:
- Chronic Periodontitis carriers - presence of proximal insertion loss ≥5 mm in more than 30% of the teeth present.
- Periodontal pocket ≥ 5mm
- Smokers who have smoked 10 or more cigarettes per day for the past five years.
- No positive history of basic periodontal treatment in the last six months.
You may not qualify if:
- Extensive prosthetic involvement.
- Using anti-inflammatories.
- Pregnant or nursing.
- Presence of systemic alterations that compromise host response or require prophylactic medication for treatment.
- History of constant use of oral antiseptics in the last six months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arthur Belem Novaes Junior
Ribeirão Preto, São Paulo, 14040-904, Brazil
Biospecimen
ephitelials cells of oral mocose
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arthur B. Novaes Junior, DDS, PhD
Study Principal Investigator
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Teacher of Periodontia- Department of Buco Maxillofacial Surgery and Traumatology and Periodontics
Study Record Dates
First Submitted
November 30, 2017
First Posted
December 13, 2017
Study Start
June 6, 2016
Primary Completion
October 16, 2017
Study Completion
November 18, 2017
Last Updated
December 13, 2017
Record last verified: 2017-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available within 2 years of study completion
- Access Criteria
- Data access criteria will be reviewed by the an external independent review panel.
Individual participant data will be made available with conclusion of study.